Jump to content
  • 0

Delisted Array BioPharma stock with Pfizer buyout - what happens?


sammyt

Question

Hello,

Apologies if this is a dumb question but I am new to this. I own(ed) some shares of Array Biopharma (NASDAQ:ARRY) that was bought by Pfizer. As per the press release on the link below, the stock has now been delisted which means I cannot sell them, and if I understand this correctly, I get $48 per share. Does anyone know how it actually works to cash this in? Will IG automatically make that money available for me to deal? The online support chat doesn't seem to know how to answer this so I am hoping someone on here can... Thanks in advance!!

https://investors.pfizer.com/investor-news/press-release-details/2019/Pfizer-Completes-Acquisition-of-Array-Biopharma/default.aspx

Link to comment

0 answers to this question

Recommended Posts

There have been no answers to this question yet

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • General Statistics

    • Total Topics
      20,040
    • Total Posts
      88,055
    • Total Members
      69,029
    • Most Online
      7,522
      10/06/21 10:53

    Newest Member
    JoseSantos
    Joined 29/09/22 09:20
  • Posts

    • Hi @HYDROCARBON Your requests have been submitted. Thank youAll the best - MongiIG
    • BRENT CRUDE OIL (LCOC1) TALKING POINTS Demand-side factors continue to dominate. Will OPEC trim supply again? BRENT CRUDE OIL FUNDAMENTAL BACKDROP Brent crude oil rallied yesterday on the back of a weaker U.S. dollar coupled with a notable decrease in U.S. crude oil stockpiles as revealed in the EIA weekly report. This morning has seen a resumption of the downward trend as the dollar is bid once more, making yesterday’s move largely attributed to oversold levels as well as quarter-end rebalancing. Markets are still focused on demand destruction and a global recession as opposed to supply-side concerns. Full article: Sep 29, 2022 | DailyFX Warren Venketas, Analyst
×
×
  • Create New...